PMID: 7541008May 1, 1995Paper

Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease

Gut
D RachmilewitzD K Podolsky

Abstract

Recent studies have suggested that nitric oxide (NO.), the product of nitric oxide synthase in inflammatory cells, may play a part in tissue injury and inflammation through its oxidative metabolism. In this study the colonic generation of oxides of nitrogen (NOx) and nitric oxide synthase activity was determined in ulcerative colitis and Crohn's disease. Colonic biopsy specimens were obtained from inflammatory bowel disease patients and from normal controls. Mucosal explants were cultured in vitro for 24 hours and NOx generation was determined. Nitric oxide synthase activity was monitored by the conversion of [3H]-L-arginine to citrulline. Median NOx generation by inflamed colonic mucosa of patients with active ulcerative colitis and Crohn's colitis was 4.2- and 8.1-fold respectively higher than that by normal human colonic mucosa. In ulcerative colitis and Crohn's colitis nitric oxide synthase activity was 10.0- and 3.8-fold respectively higher than in normal subjects. Colonic NOx generation is significantly decreased by methylprednisolone and ketotifen. The decrease in NOx generation by cultured colonic mucosa induced by methylprednisolone suggests that NO synthase activity is induced during the culture and the steroid effect...Continue Reading

References

Nov 1, 1992·Archives of Biochemistry and Biophysics·L ZhuJ S Beckman
Dec 4, 1990·European Journal of Pharmacology·N K Boughton-SmithS Moncada
Feb 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J S BeckmanB A Freeman
Jan 1, 1990·Annual Review of Pharmacology and Toxicology·L J Ignarro
Nov 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·D J Stuehr, M A Marletta
Mar 1, 1993·British Journal of Pharmacology·J AssreuyS Moncada
Apr 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·D A GellerT R Billiar
Aug 7, 1993·Lancet·N K Boughton-SmithS Moncada
Feb 20, 1993·Lancet·S J MiddletonJ O Hunter
Jan 1, 1994·Journal of Clinical Gastroenterology·G LeibowitzD Rachmilewitz
Dec 1, 1993·Gastroenterology·D RachmilewitzD K Podolsky

❮ Previous
Next ❯

Citations

Mar 1, 2012·Inflammatory Bowel Diseases·Srikanth SanthanamAparna Venkatraman
Mar 1, 1995·Digestive Diseases and Sciences·R EliakimD Rachmilewitz
Jan 20, 2004·Biochimica Et Biophysica Acta·Shalmoli BhattacharyyaSiddhartha Majumdar
Jul 1, 1998·Clinical Biochemistry·G EllisS K Makela
Mar 30, 1999·European Journal of Pharmacology·A A IzzoF Capasso
Dec 31, 2003·The Journal of Surgical Research·Melih TugayYusuf Sarioğlu
Jan 1, 1997·Peptides·N RajoraJ M Lipton
Jul 7, 2001·Free Radical Biology & Medicine·R HokariS Miura
Jul 20, 2002·Free Radical Biology & Medicine·Kevin P PavlickMatthew B Grisham
Mar 11, 1998·Current Opinion in Immunology·P RomagnaniP Parronchi
Oct 2, 2003·Prostaglandins & Other Lipid Mediators·Vijay Pal SinghShrinivas K Kulkarni
Aug 2, 2003·International Immunopharmacology·Heiko Mühl, Josef Pfeilschifter
Apr 12, 2000·Acta Physiologica Scandinavica·J SnyggA Aneman
Apr 2, 1999·Alimentary Pharmacology & Therapeutics·A Perner, J Rask-Madsen
Sep 1, 1999·Alimentary Pharmacology & Therapeutics·K PeuhkuriR Korpela
Nov 28, 2002·Alimentary Pharmacology & Therapeutics·L Kruidenier, H W Verspaget
Nov 21, 1998·European Journal of Clinical Investigation·M Guslandi
Jan 12, 2001·Clinical and Experimental Pharmacology & Physiology·T HosoiT Hayakawa
Jan 12, 2001·Clinical and Experimental Pharmacology & Physiology·M TomobuchiT Arakawa
Jan 26, 1999·Journal of Gastroenterology and Hepatology·S MiuraH Ishii
May 2, 2002·Journal of Gastroenterology and Hepatology·Atsushi HokariGotaro Toda
Apr 10, 1997·The New England Journal of Medicine·P J Barnes, M Karin
Jun 28, 2002·Acta histochemica·Irina I Stoyanova, Maya V Gulubova
Oct 29, 1998·Mediators of Inflammation·J D van BergeijkF J Zijlstra
Jul 16, 2010·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Hayet RafaChafia Touil-Boukoffa
Jan 12, 2000·Journal of Pediatric Gastroenterology and Nutrition·A K AkobengA G Thomas
Jun 9, 2001·Journal of Pediatric Gastroenterology and Nutrition·E CharmandariN Benjamin
Apr 20, 2002·Journal of Pediatric Gastroenterology and Nutrition·Tryggve LjungPer M Hellström
Feb 27, 2003·Journal of Pediatric Gastroenterology and Nutrition·L Koster-KamphuisP-Ph Forget
Jan 1, 1997·Inflammatory Bowel Diseases·M ReinshagenV E Eysselein
Jun 7, 2003·Inflammatory Bowel Diseases·Raymond K Cross, Keith T Wilson
Dec 10, 1999·Current Opinion in Clinical Nutrition and Metabolic Care·R B SteinJ L Rombeau
Jan 30, 2004·Journal of Gastroenterology and Hepatology·Kiarash RiaziAhmad Reza Dehpour

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.